Fueling the flames: Mammalian programmed necrosis in inflammatory diseases
Related Experiment Video
Updated: May 17, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
1Department of Pathology, Immunology and Virology Program, University of Massachusetts Medical School, Worcester, 01655, USA. francis.chan@umassmed.edu
Abstract:
Programmed necrosis or necroptosis is an inflammatory form of cell death driven by TNF-like death cytokines, toll-like receptors, and antigen receptors. Unlike necrosis induced by physical trauma, a dedicated pathway is involved in programmed necrosis. In particular, a kinase complex composed of the receptor interacting protein kinase 1 (RIPK1) and RIPK3 is a central step in necrotic cell death. Assembly and activation of this RIPK1-RIPK3 "necrosome" is critically controlled by protein ubiquitination, phosphorylation, and caspase-mediated cleavage events. The molecular signals cumulate in formation of intracellular vacuoles, organelle swelling, internal membrane leakage, and eventually plasma membrane rupture. These morphological changes can result in spillage of intracellular adjuvants to promote inflammation and further exacerbate tissue injury. Because of the inflammatory nature of necrosis, it is an attractive pathway for therapeutic intervention in acute inflammatory diseases.
Insights
Programmed necrosis, or necroptosis, is an inflammatory cell death pathway regulated by specific proteins like RIPK1 and RIPK3. Its inflammatory nature makes it a target for treating inflammatory diseases.
Area of Science:
- Cell Biology
- Immunology
- Molecular Biology
Background:
- Programmed necrosis (necroptosis) is an inflammatory cell death pathway.
- It is triggered by specific signaling molecules like TNF-like death cytokines.
- This pathway differs from necrosis caused by physical trauma.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying programmed necrosis.
- To highlight the role of key regulatory proteins in necroptosis.
- To identify necroptosis as a potential therapeutic target for inflammatory conditions.
Main Methods:
- Investigated the role of receptor interacting protein kinase 1 (RIPK1) and RIPK3 in necroptosis.
- Examined the regulation of the RIPK1-RIPK3 complex (necrosome) by ubiquitination, phosphorylation, and cleavage.
- Analyzed the morphological and cellular consequences of necroptosis.
Main Results:
- Identified a central kinase complex of RIPK1 and RIPK3 in programmed necrosis.
- Demonstrated that necrosome assembly is controlled by post-translational modifications.
- Observed characteristic cellular changes including vacuole formation and membrane rupture.
Conclusions:
- Programmed necrosis is a tightly regulated inflammatory cell death process.
- The RIPK1-RIPK3 necrosome is a key mediator of necroptosis.
- The inflammatory nature of necroptosis presents opportunities for therapeutic intervention in inflammatory diseases.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury IV: Necrosis
Inflammation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Chronic Inflammation: Introduction
Cellular Injury IlI: Cellular Death
